Defining methods to improve eSource site start-up practices
- PMID: 39651464
- PMCID: PMC11625275
- DOI: 10.1016/j.conctc.2024.101391
Defining methods to improve eSource site start-up practices
Abstract
Background: eSource software that transfers patient electronic health record data into a clinical trial electronic case report form holds promise for increasing data quality while reducing data collection, monitoring and source document verification costs. Integrating eSource into multicenter clinical trial start-up procedures could facilitate the use of eSource technologies in clinical trials.
Methods: We conducted a qualitative integrative analysis to identify eSource site start-up key steps, challenges that might occur in executing those steps, and potential solutions to those challenges. We then conducted a value analysis to determine the challenges and solutions with the greatest impacts for eSource implementation teams.
Results: There were 16 workshop participants: 10 pharmaceutical sponsor, 3 academic site, and 1 eSource vendor representative. Participants identified 36 Site Start-Up Key Steps, 11 Site Start-Up Challenges, and 14 Site Start-Up Solutions for eSource-enabled studies. Participants also identified 77 potential impacts of the Challenges upon the Site Start-Up Key Steps and 70 ways in which the Solutions might impact Site Start-Up Challenges. The most important Challenges were: [1] not being able to identify a site eSource champion and [2] not agreeing on an eSource approach. The most important Solutions were: [1] eSource vendors accepting electronic data in the Health Level 7 Fast Healthcare Interoperability Resources (HL7® FHIR®) standard, [2] creating standard content for eSource-related legal documents, and [3] creating a common eSource site readiness checklist.
Conclusions: Site start-up for eSource-enabled multi-center clinical trials is a complex socio-technical problem. This study's Start-Up Solutions provide initial steps for scalable eSource implementation.
Keywords: Clinical research; Clinical trial; Electronic data capture; Electronic health records; Health information technology; eSource.
© 2024 The Authors.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Amy E. Cramer: Employment, Johnson & Johnson Innovative Medicine. Linda S. King: Employment, Astellas Pharma. Michael T. Buckley: Employment, Memorial Sloan Kettering Cancer Center. Peter Casteleyn: Employment, Johnson & Johnson Innovative Medicine. Cory Ennis: Employment: Duke University School of Medicine. Muayad Hamidi: Employment: UT Health San Antonio. Gonçalo M. C. Rodrigues: Employment, Janssen-Cilag. Denise C. Snyder: Employment, Duke University School of Medicine. Aruna Vattikola: Employment, Merck & Co., Inc. Eric L. Eisenstein: I have nothing to declare.
Update of
-
Improving eSource Site Start-Up Practices.Res Sq [Preprint]. 2024 May 24:rs.3.rs-4414917. doi: 10.21203/rs.3.rs-4414917/v1. Res Sq. 2024. Update in: Contemp Clin Trials Commun. 2024 Nov 14;42:101391. doi: 10.1016/j.conctc.2024.101391. PMID: 38826202 Free PMC article. Updated. Preprint.
References
-
- Getz K.A., Campo R.A. New benchmarks characterizing growth in protocol design complexity. Ther Innov Regul Sci. 2018;52(1):22–28. - PubMed
-
- Getz K.A., Campo R.A. Trial watch: trends in clinical trial design complexity. Nat. Rev. Drug Discov. 2017;16(5):307. - PubMed
-
- DiMasi J.A., Grabowski H.G., Hansen R.W. Innovation in the pharmaceutical industry: new estimates of R&D costs. J. Health Econ. 2016;47:20–33. - PubMed
-
- Eisenstein E.L., Lemons P.W., 2nd, Tardiff B.E., et al. Reducing the costs of phase III cardiovascular clinical trials. Am. Heart J. 2005;149(3):482–488. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources